Ligand Pharmaceuticals' SARM LGD-4033 study data presented at the Gerontology Society of America...
Ligand Pharmaceuticals Incorporated today announced that data from a preclinical study on its selective androgen receptor modulator (SARM) LGD-4033 was featured in a poster presentation at the 62nd Annual Meeting of the...



